Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BASAGLAR DIN 02461528

Status: Marketed
Holder: ELI LILLY CANADA INC
Molecule: INSULIN GLARGINE
Available to quote

Health Canada record

Active ingredient(s)INSULIN GLARGINE 100 UNIT
Dosage formSolution
RouteSubcutaneous
ScheduleSCHEDULE D
ClassHuman
ATCA10AE04 INSULIN GLARGINE
Original market date18-Aug-2017
Current status date18-Aug-2017
SourceHealth Canada DPD

Establishment licence of the holder

Eli Lilly Canada Inc. — licence 100164, currently licensed, last inspection rating C (2026-03-24).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing INSULIN GLARGINE

DINProductCompanyFormStrengthStatus
02444844BASAGLARELI LILLY CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02294338LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02251930LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02245689LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITMarketed
02526441SEMGLEEBIOCON SDN.BHDSolutionINSULIN GLARGINE 100 UNITMarketed
02478293SOLIQUASANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNIT; LIXISENATIDE 33 MCGMarketed
02493373TOUJEO DOUBLESTARSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 300 UNITMarketed
02441829TOUJEO SOLOSTARSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 300 UNITMarketed
02444852BASAGLARELI LILLY CANADA INCSolutionINSULIN GLARGINE 100 UNITCancelled Post Market
02280418LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITCancelled Pre Market
02276410LANTUSSANOFI-AVENTIS CANADA INCSolutionINSULIN GLARGINE 100 UNITCancelled Pre Market

Notices of Compliance

NOCDateSubmissionReason
189512017-02-10Supplement to a New Drug Submission (SNDS)ADDITION OF A SECONDARY CONTAINER CLOSURE SYSTEM

International API supply for INSULIN GLARGINE

4 active FDA Drug Master Files.

Request a quote for BASAGLAR

How to read a Canadian DIN record